The SMARTER Cardiomyopathy Study

Last updated: March 5, 2024
Sponsor: Imperial College London
Overall Status: Active - Recruiting

Phase

N/A

Condition

Heart Disease

Congestive Heart Failure

Cardiovascular Disease

Treatment

Blood Sample Collection

Clinical Study ID

NCT05750147
22IC7783
  • All Genders

Study Summary

Cardiomyopathies are diseases of the heart muscle. Known genetic factors may account for some cardiomyopathy cases but there is still much to understand about the genetic and environmental causes and how the disease progresses.

Finding new ways to diagnose and treat cardiomyopathies could improve the health and well-being of patients with these conditions.

This study will collect data from individuals with cardiomyopathy or related heart muscle disease, or with a possible genetic predisposition to cardiomyopathy, and follow them over time to observe the progress of their heart and health. This study will collect DNA, blood samples, and detailed clinical & lifestyle information at the start of the study, and data collected during routine healthcare visits over time.

  • learn what causes cardiomyopathy, and therefore how to treat it

  • understand why cardiomyopathy progresses differently in different people, to improve the ability to recognise who will benefit from different treatments at different times

The investigators will collaborate with other centres internationally to collect a large of group of participants with similar cardiomyopathies, providing power to identify new pathways that cause disease and ways of predicting which participants are at risk of having more severe disease.

Eligibility Criteria

Inclusion

Inclusion Criteria: Adults with the capacity to consent Children with parental/guardian consent Male and Female Meeting the following criteria:

  1. Patients with a confirmed diagnosis of cardiomyopathy or related condition
  2. Patients with a family member with cardiomyopathy, or a related condition
  3. Patients with a genetic variant that may predispose to cardiomyopathy, or a relatedcondition

Exclusion

Exclusion Criteria: Patients without the capacity to provide informed consent

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Blood Sample Collection
Phase:
Study Start date:
March 01, 2023
Estimated Completion Date:
August 01, 2027

Connect with a study center

  • Guys & St Thomas' NHS Foundation Trust

    London,
    United Kingdom

    Active - Recruiting

  • Kings College Hospital

    London,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.